Related Experiment Video
Updated: Aug 3, 2026
07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Isolation and characterization of impurities in docetaxel
R Vasu Dev1, J Moses Babu, K Vyas
1Department of Analytical Research, Discovery Research, Dr. Reddy's Laboratories Ltd., Bollaram Road, Miyapur, Hyderabad 500049, Andhra Pradesh, India.
Journal of Pharmaceutical and Biomedical Analysis
|December 7, 2005
Summary
This study details the identification and characterization of four docetaxel impurities using advanced chromatography and spectroscopy. Two impurities are process-related, while two are isomers, offering insights into docetaxel synthesis.
Area of Science:
- Pharmaceutical Chemistry
- Analytical Chemistry
- Organic Chemistry
Background:
- Docetaxel is a crucial chemotherapeutic agent.
- Process development requires rigorous impurity profiling.
- Understanding impurity formation is key to drug quality.
Purpose of the Study:
- To identify and characterize polar and non-polar impurities in docetaxel.
- To elucidate the structural identities of detected impurities.
- To differentiate between process-related impurities and isomers.
Main Methods:
- High-performance liquid chromatography (HPLC) for impurity detection.
- Medium-pressure liquid chromatography (MPLC) for impurity isolation.
- Nuclear magnetic resonance (NMR) spectroscopy (1D and 2D) for structural elucidation.
- Single crystal X-ray diffraction (XRD) for structural confirmation.
Main Results:
- Four docetaxel impurities (I, II, III, IV) were detected and isolated.
- Impurities I and IV were identified as isomers.
- Impurities II and III were identified as process-related.
- The structures were confirmed using NMR and XRD.
Conclusions:
- The study successfully identified and characterized four docetaxel impurities.
- Distinguishing between process-related impurities and isomers is critical for quality control.
- The findings provide valuable information for optimizing docetaxel manufacturing processes.
